Antagonists of growth hormone-releasing hormone suppress in vivo tumor growth and gene expression in triple negative breast cancers

Por Perez, Roberto, Schally, Andrew V., Vidaurre, Irving, Rincon, Ricardo, Block, Norman L., Rick, Ferenc G.
Publicado em 2012

Inhibition of U-87 MG glioblastoma by AN-152 (AEZS-108), a targeted cytotoxic analog of luteinizing hormone-releasing hormone

Por Jaszberenyi, Miklos, Schally, Andrew V., Block, Norman L., Nadji, Mehrdad, Vidaurre, Irving, Szalontay, Luca, Rick, Ferenc G.
Publicado em 2013

Effects of a growth hormone-releasing hormone antagonist on telomerase activity, oxidative stress, longevity, and aging in mice

Por Banks, William A., Morley, John E., Farr, Susan A., Price, Tulin O., Ercal, Nuran, Vidaurre, Irving, Schally, Andrew V.
Publicado em 2010

Powerful Inhibition of Experimental Human Pancreatic Cancers by Receptor Targeted Cytotoxic LH-RH analog AEZS-108

Por Szepeshazi, Karoly, Schally, Andrew V., Block, Norman L., Halmos, Gabor, Nadji, Mehrdad, Szalontay, Luca, Vidaurre, Irving, Abi-Chaker, Andrew, Rick, Ferenc G.
Publicado em 2013

Antagonists of growth hormone-releasing hormone (GHRH) reduce prostate size in experimental benign prostatic hyperplasia

Por Rick, Ferenc G., Schally, Andrew V., Block, Norman L., Nadji, Mehrdad, Szepeshazi, Karoly, Zarandi, Marta, Vidaurre, Irving, Perez, Roberto, Halmos, Gabor, Szalontay, Luca
Publicado em 2011

Receptor-targeted therapy of human experimental urinary bladder cancers with cytotoxic LH-RH analog AN-152 (AEZS-108)

Por Szepeshazi, Karoly, Schally, Andrew V., Keller, Gunhild, Block, Norman L., Benten, Daniel, Halmos, Gabor, Szalontay, Luca, Vidaurre, Irving, Jaszberenyi, Miklos, Rick, Ferenc G.
Publicado em 2012

Novel GHRH antagonists suppress the growth of human malignant melanoma by restoring nuclear p27 function

Por Szalontay, Luca, Schally, Andrew V, Popovics, Petra, Vidaurre, Irving, Krishan, Awtar, Zarandi, Marta, Cai, Ren-Zhi, Klukovits, Anna, Block, Norman L, Rick, Ferenc G
Publicado no Cell Cycle (2014)

Potentiation of cytotoxic chemotherapy by growth hormone-releasing hormone agonists

Por Jaszberenyi, Miklos, Rick, Ferenc G., Popovics, Petra, Block, Norman L., Zarandi, Marta, Cai, Ren-Zhi, Vidaurre, Irving, Szalontay, Luca, Jayakumar, Arumugam R., Schally, Andrew V.
Publicado em 2014

Beneficial effects of growth hormone-releasing hormone agonists on rat INS-1 cells and on streptozotocin-induced NOD/SCID mice

Por Zhang, Xianyang, Cui, Tengjiao, He, Jinlin, Wang, Haibo, Cai, Renzhi, Popovics, Petra, Vidaurre, Irving, Sha, Wei, Schmid, Janine, Ludwig, Barbara, Block, Norman L., Bornstein, Stefan R., Schally, Andrew V.
Publicado no Proc Natl Acad Sci U S A (2015)

Shrinkage of experimental benign prostatic hyperplasia and reduction of prostatic cell volume by a gastrin-releasing peptide antagonist

Por Rick, Ferenc G., Abi-Chaker, Andrew, Szalontay, Luca, Perez, Roberto, Jaszberenyi, Miklos, Jayakumar, Arumugam R., Shamaladevi, Nagarajarao, Szepeshazi, Karoly, Vidaurre, Irving, Halmos, Gabor, Krishan, Awtar, Block, Norman L., Schally, Andrew V.
Publicado em 2013

New therapeutic approach to heart failure due to myocardial infarction based on targeting growth hormone-releasing hormone receptor

Por Kanashiro-Takeuchi, Rosemeire M., Szalontay, Luca, Schally, Andrew V., Takeuchi, Lauro M., Popovics, Petra, Jaszberenyi, Miklos, Vidaurre, Irving, Zarandi, Marta, Cai, Ren-Zhi, Block, Norman L., Hare, Joshua M., Rick, Ferenc G.
Publicado no Oncotarget (2015)